Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on the Safety and Effectiveness of Trastuzumab Deruxtecan with Drug Combination for Patients with HER2+ Resectable Esophagogastric Cancer

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Austria Germany
  • Study of Bemarituzumab with Irinotecan, Paclitaxel, Ramucirumab, or Trifluridine/Tipiracil for Advanced Stomach or Gastroesophageal Cancer in Patients After Chemotherapy

    Not yet recruiting

    1 1 1
    Germany Spain
  • Study on [68Ga]Ga-FAPI-46 PET/CT Imaging for Better Diagnosis in Patients with Pancreatic and Gastroesophageal Cancer

    Not yet recruiting

    1 1 1
    Denmark
  • Study on Organ Preservation for Early Stage Esophageal Cancer Using Durvalumab and Chemoradiation for Patients Eligible for Surgery

    Not recruiting

    1 1 1
    Germany
  • Study on Atezolizumab with Drug Combination for Patients with Gastric Cancer and Esophagogastric Junction Adenocarcinoma

    Not recruiting

    1 1 1 1
    Germany
  • Study of Nivolumab or Placebo for Patients with Removed Esophageal or Gastroesophageal Junction Cancer

    Not recruiting

    1 1 1
    Investigated drugs:
    Belgium Czechia Denmark France Germany Ireland +4
  • Study of Retifanlimab, Capecitabine, and Oxaliplatin for First-Line Treatment in Patients with Metastatic Esophagogastric Cancer

    Not recruiting

    1 1
    Investigated drugs:
    The Netherlands
  • Study on Regorafenib and Nivolumab for Patients with Advanced Gastro-Oesophageal Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany Italy Spain
  • Study on [68Ga]Ga-FAPI-46 and Iodixanol for Better Imaging in Patients with Pancreatic and Gastroesophageal Cancer

    Not recruiting

    1 1 1
    Denmark
  • Study on 68Ga-FAPI-46 and Fludeoxyglucose (18F) for Diagnosing Stomach and Gastroesophageal Junction Cancer in Patients Undergoing Chemotherapy

    Not recruiting

    1 1 1
    Investigated diseases:
    Denmark